Editor
An experimental drug initially developed to fight cancer cut the risk of death for people hospitalized with COVID by half, according to a study published Wednesday.
Buy Now | Our best subscription plan now has a special price
The drug, sabizabulin, seemed to be more effective than others that have been authorized for severely ill COVID patients. Veru, the company in Miami that developed the drug, has applied to the Food and Drug…
